Advertisement

N.B. reports 4 deaths in new COVID-19 update as hospitalizations, cases rise

Click to play video: 'COVID-19: 4 deaths, hospitalizations on the rise in N.B.'
COVID-19: 4 deaths, hospitalizations on the rise in N.B.
It’s not long into summer and New Brunswick is seeing an unexpected uptick in COVID-19 cases and hospitalizations. New figures on the province’s CovidWatch page show while the demand for vaccines is growing, so is the presence of the virus. Robert Lothian reports – Jul 5, 2022

New Brunswick health officials reported four deaths linked to COVID-19 in the latest weekly epidemiology update.

The number is up by one compared to last week’s report.

Hospital admissions were also up in the seven-day period from June 26 to July 2. The province saw 22 new admissions, compared to six reported last week.

There are 19 active COVID-19 hospitalizations remaining, up by four compared to last week. One person is in intensive care.

Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day.

Get daily National news

Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

According to the Tuesday report, the highest portion of hospitalizations for COVID-19 involves individuals aged 60 to 79.

It also said, “Individuals that are unprotected by vaccine continue to have the highest rate of hospitalization for COVID-19 and death.”

Story continues below advertisement

New infection numbers are also rising. The province reported 768 new PCR-confirmed cases of COVID-19 in the week ending July 2, as well as 1,147 self-reported rapid test positives — twice the amount reported last week.

In New Brunswick, about 52.8 per cent of eligible adults have received at least three doses of a COVID-19 vaccine, with another 375 shots given out in the seven-day period. About 88.2 per cent have received at least two doses, and 93.3 per cent received at least one dose.

Sponsored content

AdChoices